UCLA Broad Stem Cell Research Center receives $5 million CIRM grant for research training program ucla.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ucla.edu Daily Mail and Mail on Sunday newspapers.
July 7, 2021
Rando, who was chosen after an international search, is currently a professor of neurology and neurological sciences at the medical school at Stanford University, where he also serves as director of the Glenn Center for the Biology of Aging and deputy director of the Stanford Center on Longevity. In addition, he is chief of neurology at the Veterans Affairs Palo Alto Health Care System.
His appointment is effective Oct. 1.
“As a trailblazing clinical investigator and inspired scientific leader, Tom is well positioned to lead the Broad Stem Cell Research Center to even greater successes,” said UCLA Chancellor Gene Block. “His accomplishments as a director of numerous multidisciplinary and collaborative scientific programs, both at Stanford and the VA, are a testament to his abilities as a champion for innovative research, a mentor and an administrator.”
April 22, 2021
UCLA In the News lists selected mentions of UCLA in the world’s news media. Some articles may require registration or a subscription to view. See more UCLA In the News.
Over the course of the pandemic, Los Angeles County has confirmed 1.18 million Covid-19 cases. But close to 40% of the population may have actually been infected already, said Shira Shafir, an associate professor of epidemiology at the University of California, Los Angeles. That isn’t high enough for herd immunity, but may have left a large chunk of population not susceptible to the virus. … “I think for right now, until we get more of the population vaccinated and approach more towards herd immunity, we always have a certain level of risk of outbreak and additional surges,” said Johnese Spisso, chief executive of the UCLA Hospital System.
Stem cell therapy can repair brain damage and improve memory function in mice
A one-time injection of an experimental stem cell therapy can repair brain damage and improve memory function in mice with conditions that replicate human strokes and dementia, a new UCLA study finds.
Dementia can arise from multiple conditions, and it is characterized by an array of symptoms including problems with memory, attention, communication and physical coordination. The two most common causes of dementia are Alzheimer s disease and white matter strokes -; small strokes that accumulate in the connecting areas of the brain. It s a vicious cycle: The two leading causes of dementia are almost always seen together and each one accelerates the other, said Dr. S. Thomas Carmichael, senior author of the study and interim director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.